by PRISMS | May 28, 2020 | Research Study
Rhythm Pharmaceuticals is currently recruiting for a Phase 2 clinical study of an investigational therapy to help reduce weight and hunger in individuals diagnosed with Smith-Magenis Syndrome and rare genetic diseases of obesity. The study is enrolling individuals:...
